Q.Liver software for the planning of treatment of liver cancer via transarterial radioembolization with yttrium-90 resin microspheres based on single-photon emission computed tomography-computed tomography
Abstract
Background: Hepatocellular carcinoma (HCC) and liver-dominant metastases remain major causes of cancer mortality, and yttrium-90 transarterial radioembolization (TARE) offers a vital treatment option for unresectable cases. Accurate dosimetry is critical for maximizing tumor control while minimizing lung toxicity, yet conventional planar scintigraphy may overestimate lung shunt and compromise therapeutic efficacy. This study evaluated the value of Q.Liver software in planning yttrium-90 TARE for liver cancer. Methods: of each method were calculated. Results: , were higher in the Q.Liver method than in the planar method. This led to changes in 44.19% (19/43) of the treatment plans. Conclusions: , leading to changes in 44.19% of the treatment plans involving yttrium-90 resin microsphere TARE.
Fields of Study & Subjects
Hepatocellular Carcinoma Treatment and Prognosis
Advanced Radiotherapy Techniques
Advanced X-ray and CT Imaging
Publication details
- Journal / source
- Quantitative Imaging in Medicine and Surgery
- Publisher
- AME Publishing Company
- Volume
- 16
- Issue
- 2
- Pages
- 109–109
- Publication date
- 28 January 2026
- Language
- EN